Healthcare provider profile · identity verified

Michael Eric Walton, MD

Family Practice · ARLINGTON, OH · NPI 1326088238

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	316	73
Atorvastatin Calcium	Atorvastatin Calcium	308	65
Carvedilol	Carvedilol	257	55
Pantoprazole Sodium	Pantoprazole Sodium	256	68
Amlodipine Besylate	Amlodipine Besylate	251	58
Levothyroxine Sodium	Levothyroxine Sodium	245	54
Metformin Hcl	Metformin Hcl	241	67
Montelukast Sodium	Montelukast Sodium	238	91
Losartan Potassium	Losartan Potassium	223	55
Simvastatin	Simvastatin	194	50
Gabapentin	Gabapentin	174	42
Alprazolam	Alprazolam	170	29
Glipizide	Glipizide	169	43
Tamsulosin Hcl	Tamsulosin Hcl	168	40
Rosuvastatin Calcium	Rosuvastatin Calcium	154	37
Metoprolol Tartrate	Metoprolol Tartrate	146	31
Alendronate Sodium	Alendronate Sodium	117	35
Meloxicam	Meloxicam	115	35
Furosemide	Furosemide	112	27
Pravastatin Sodium	Pravastatin Sodium	105	28
Diclofenac Sodium	Diclofenac Sodium	104	46
Nabumetone	Nabumetone	100	41
Hydrochlorothiazide	Hydrochlorothiazide	97	24
Buspirone Hcl	Buspirone Hcl	89	20
Potassium Chloride	Potassium Chloride	88	19
Ropinirole Hcl	Ropinirole Hcl	87	22
Clopidogrel	Clopidogrel Bisulfate	81	20
Memantine Hcl	Memantine Hcl	80	19
Prednisone	Prednisone	80	56
Zolpidem Tartrate	Zolpidem Tartrate	79	19
Mirtazapine	Mirtazapine	75	23
Baclofen	Baclofen	74	29
Cephalexin	Cephalexin	73	56
Allopurinol	Allopurinol	69	15
Sertraline Hcl	Sertraline Hcl	68	16
Azithromycin	Azithromycin	60	52
Meclizine Hcl	Meclizine Hcl	60	15
Omeprazole	Omeprazole	59	15
Jardiance	Empagliflozin	58	14
Metoprolol Succinate	Metoprolol Succinate	53	13
Albuterol Sulfate Hfa	Albuterol Sulfate	51	14
Eliquis	Apixaban	50	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Donepezil Hcl	Donepezil Hcl	48	11
Fluticasone Propionate	Fluticasone Propionate	48	15
Pregabalin	Pregabalin	48	11
Finasteride	Finasteride	43	16
Fenofibrate	Fenofibrate Nanocrystallized	40	11
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Gemfibrozil	Gemfibrozil	40	suppressed
Glipizide Er	Glipizide	39	suppressed
Lorazepam	Lorazepam	39	suppressed
Tramadol Hcl	Tramadol Hcl	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Atenolol	Atenolol	29	suppressed
Pentoxifylline	Pentoxifylline	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Ozempic	Semaglutide	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	11
Diltiazem Hcl	Diltiazem Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Sucralfate	Sucralfate	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Clonidine Hcl	Clonidine Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	15
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Famotidine	Famotidine	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Metronidazole	Metronidazole	19	15
Topiramate	Topiramate	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	12
Novolog Flexpen	Insulin Aspart	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Propranolol Hcl	Propranolol Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Diazepam	Diazepam	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Amoxicillin	Amoxicillin	12	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fingolimod	Fingolimod Hcl	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error